OMCL Stock Financial Analysis - Omnicell, Inc. (BMV) Stock

Overview

Omnicell, Inc., based in the United States, operates primarily within the healthcare industry, specializing in automated solutions and medication management. The company focuses on improving operational efficiency and patient care at healthcare facilities through innovative pharmacy automation, data intelligence, and medication management systems. Key projects include the development of their Automated Dispensing Cabinets and the XT Series, which streamline medication dispensing processes and enhance safety. Another significant initiative is their Performance Center, which utilizes predictive analytics to optimize inventory management and reduce medication waste. These projects highlight Omnicell’s commitment to advancing healthcare through technology-driven solutions that support pharmacists, nurses, and healthcare professionals in delivering effective patient care.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Omnicell, Inc. as of June 30, 2025 is 1,149.53 MM.
The operating income for Omnicell, Inc. as of June 30, 2025 is 17.45 MM.
The net income for Omnicell, Inc. as of June 30, 2025 is 23.09 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	1,149.53	17.45	23.09
2025-03-31	1,135.76	12.55	21.18
2024-12-31	1,112.24	5.49	12.53
2024-09-30	1,064.21	-31.57	-17.69
2024-06-30	1,080.45	-23.43	-20.76
2024-03-31	1,102.63	-18.18	-21.05
2023-12-31	1,147.11	-9.33	-20.37
2023-09-30	1,185.94	-31.12	-34.40
2023-06-30	1,235.34	-12.69	-23.18
2023-03-31	1,267.75	-3.94	-17.57
2022-12-31	1,295.95	29.86	5.65
2022-09-30	1,309.31	67.73	48.04
2022-06-30	1,257.65	75.57	60.58
2022-03-31	1,199.00	87.26	71.94
2021-12-31	1,132.02	98.53	77.85
2021-09-30	1,070.19	106.65	80.25
2021-06-30	987.48	87.41	59.73
2021-03-31	914.37	57.86	35.01
2020-12-31	892.21	51.99	32.19
2020-09-30	891.30	47.45	37.91
2020-06-30

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31	0.46	0.45
2024-12-31	0.27	0.27
2024-09-30	-0.39	-0.39
2024-06-30	-0.46	-0.45
2024-03-31	-0.46	-0.46
2023-12-31	-0.45	-0.45
2023-09-30	-0.76	-0.77
2023-06-30	-0.52	-0.53
2023-03-31	-0.39	-0.39
2022-12-31	0.13	0.12
2022-09-30	1.09	1.01
2022-06-30	1.38	1.26
2022-03-31	1.64	1.49
2021-12-31	1.79	1.62
2021-09-30	1.86	1.73
2021-06-30	1.39	1.32
2021-03-31	0.82	0.79
2020-12-31	0.76	0.74
2020-09-30	0.89	0.87
2020-06-30	1.16	1.13

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Omnicell, Inc. as of June 30, 2025 is 147.75 MM.
The cash from investing activities for Omnicell, Inc. as of June 30, 2025 is -58.57 MM.
The cash from financing activities for Omnicell, Inc. as of June 30, 2025 is -238.31 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	147.75	-58.57	-238.31
2025-03-31	163.69	-56.19	-243.47
2024-12-31	187.72	-52.79	-235.58
2024-09-30	169.82	-51.60	11.98
2024-06-30	204.07	-52.45	11.25
2024-03-31	218.28	-53.72	31.48
2023-12-31	181.09	-55.02	23.42
2023-09-30	224.83	-59.90	13.85
2023-06-30	189.00	-61.58	20.08
2023-03-31	106.55	-53.58	15.03
2022-12-31	77.78	-58.67	-20.95
2022-09-30	55.26	-233.80	-17.85
2022-06-30	77.07	-411.57	-8.62
2022-03-31	158.40	-418.10	-0.35
2021-12-31	231.81	-412.50	47.36
2021-09-30	248.62	-456.81	61.10
2021-06-30	242.32	-273.13	510.99
2021-03-31	218.05	-279.22	505.63
2020-12-31	185.87	-279.87	456.27
2020-09-30	144.24	-58.08	405.35
2020-06-30

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30

Management Effectiveness

The roe for Omnicell, Inc. as of June 30, 2025 is 0.00.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30		0.00
2025-03-31		0.00
2024-12-31		0.00
2024-09-30		0.00
2024-06-30		0.00
2024-03-31		0.00
2023-12-31		0.00
2023-09-30		0.00
2023-06-30		0.00
2023-03-31		0.00
2022-12-31		0.00
2022-09-30		0.00
2022-06-30		0.00
2022-03-31		0.00
2021-12-31		0.00
2021-09-30		0.00
2021-06-30		0.00
2021-03-31		0.00
2020-12-31	0.03	0.04	0.02	0.24	0.12
2020-09-30	0.03	0.05	0.03	0.34	0.10
2020-06-30	0.04	0.06	0.05	0.05	0.16

Gross Margins

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31	0.47	0.04	0.04
2020-09-30	0.47	0.04	0.05
2020-06-30	0.48	0.05	0.07

DE:OC9	€28.00
US:OMCL	$32.11